Things We Do for No Reason™: Routine pretreatment with a P2Y12 receptor inhibitor before invasive coronary angiography for patients with a non‐ST elevation acute coronary syndrome

Author:

O'Malley Kevin1ORCID,Hwang Yoseob Joseph12,Trost Jeffrey1,Feldman Leonard13ORCID

Affiliation:

1. Department of Medicine, Division of Hospital Medicine at Johns Hopkins Hospital Johns Hopkins University School of Medicine Baltimore Maryland USA

2. Center for Drug Safety and Effectiveness Johns Hopkins University Baltimore Maryland USA

3. Department of Pediatrics Johns Hopkins University School of Medicine Baltimore Maryland USA

Publisher

Wiley

Subject

Assessment and Diagnosis,Care Planning,Health Policy,Fundamentals and skills,General Medicine,Leadership and Management

Reference17 articles.

1. 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

2. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Lawton JS;Circulation,2022

3. Pharmacology before, during and after percutaneous coronary intervention

4. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3